Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Boston Scientific Corp.
Headquarters: Marlborough, MA, United States of America
Website: http://www.bostonscientific.c...
Year Founded: 1979
Status: Public
Industry Sector: HealthTechnology
CEO: Michael F. Mahoney, MBA
Number Of Employees: 53,000
Enterprise Value: $143,656,588,000
PE Ratio: 76.45
Exchange/Ticker 1: NYSE:BSX
Exchange/Ticker 2: N/A
Latest Market Cap: $140,745,146,368
BioCentury | Jun 7, 2022
Product Development
The CD123 pipeline behind Elzonris
CAR T therapies comprise six of the 14 programs, with new data from Cellectis highlighting the modality’s potential for selective killing
BioCentury | Feb 24, 2022
Management Tracks
Philip to succeed Marrazzo at Spark
Plus LaCaze joins Mnemo and updates from Sumitomo, Veracyte, Totus and more
BioCentury | Oct 28, 2021
Management Tracks
Labinger out as Checkmate CEO
Plus: Travecta, MTS Health Partners, Elevar and Y Combinator
BioCentury | Apr 17, 2020
Product Development
BARDA’s $483M commitment to Moderna headlines flurry of COVID-19 vaccine updates
Inovio receives CEPI grant; Sinovac-Dynavax, Soligenix-Boston Scientific in adjuvant deals
BioCentury | Dec 16, 2019
Company News
Architects behind Celgene takeout step down as Flagship adds another industry vet in Biondi
Items per page:
1 - 10 of 339